| Quarter | Score |
|---|---|
| 2022-Q1 | 49.5 |
| 2022-Q3 | 40.8 |
| 2022-Q4 | 51.3 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 63.4 |
| 2023-Q3 | 48.2 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 74.2 |
| 2024-Q2 | 74.5 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 81.5 |
| 2025-Q1 | 81.7 |
| 2025-Q2 | 81.4 |
| 2025-Q3 | 82.7 |
| 2025-Q4 | 78.1 |
| 2026-Q1 | 80.9 |
| 2026-Q2 | 81.5 |
Funds reducing exposure or consensus momentum fading
Trading 19.5% below funds' estimated purchase price
2 of 18 tracked funds hold ACHC. Avg conviction: 1.7%. Net trimming. First tracked at $32.21 (current -19.5% vs tracked).
Greenlight Capital has 3.3% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 3.3% | Reduce |
| Citadel Advisors | 0.0% | Reduce |